This content is from: Premium

Jeffrey Ubben’s ValueAct Scores in Good Year for Activists

The San Francisco–based manager trounced the market on a gross basis with its concentrated bets on technology and pharmaceuticals stocks.

Jeffrey Ubben’s ValueAct Capital was one of the better-performing activist fund managers — and hedge fund managers in general — in 2013. The San Francisco–based firm’s main fund gained about 29.5 percent net of fees last year. This is in line with the S&P 500, which of course does not charge

To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.

Related Content